Endocrine and Adrenergic Pharmacological Intervention in Diseases of the Prostate

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1998 May 13

PMID 9578179

Citations 1

Authors

A Rane

Affiliations

Soon will be listed here.

Citing Articles

A 6-month large-scale study into the safety of tamsulosin.

Michel M, Bressel H, Goepel M, Rubben H Br J Clin Pharmacol. 2001; 51(6):609-14.

PMID: 11422021 PMC: 2014481. DOI: 10.1046/j.0306-5251.2001.01388.x.

References

Jorgensen T, TVETER K, Jorgensen L . Total androgen suppression: experience from the Scandinavian Prostatic Cancer Group Study No. 2. Eur Urol. 1993; 24(4):466-70. DOI: 10.1159/000474351. View

Stege R, Eriksson A, Henriksson P, Carlstrom K . Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroids. Int J Androl. 1987; 10(4):581-7. DOI: 10.1111/j.1365-2605.1987.tb00357.x. View

Ross R, Bernstein L, Lobo R, Shimizu H, Stanczyk F, Pike M . 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 1992; 339(8798):887-9. DOI: 10.1016/0140-6736(92)90927-u. View

Michel M, Kenny B, Schwinn D . Classification of alpha 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(1):1-10. DOI: 10.1007/BF00169183. View

McConnell J . Prostatic growth: new insights into hormonal regulation. Br J Urol. 1995; 76 Suppl 1:5-10. View

White J . I. The Results of Double Castration in Hypertrophy of the Prostate. Ann Surg. 1895; 22(1):1-80. PMC: 1424827. DOI: 10.1097/00000658-189507000-00001. View

Habib F, GRANT E . Molecular and cellular biology of the prostate: is it clinically relevant?. Br J Urol. 1996; 78(4):546-51. DOI: 10.1046/j.1464-410x.1996.13210.x. View

Tyrrell C, Altwein J, Klippel F, Varenhorst E, Lunglmayr G, Boccardo F . A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group. J Urol. 1991; 146(5):1321-6. DOI: 10.1016/s0022-5347(17)38080-1. View

Yamada S, Tanaka C, Kimura R, Kawabe K . Alpha 1-adrenoceptors in human prostate: characterization and binding characteristics of alpha 1-antagonists. Life Sci. 1994; 54(24):1845-54. DOI: 10.1016/0024-3205(94)90141-4. View

10.

Young R, Brogden R . Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension. Drugs. 1988; 35(5):525-41. DOI: 10.2165/00003495-198835050-00003. View

11.

Denis L, Carnelro de Moura J, Bono A, Sylvester R, Whelan P, Newling D . Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center. Urology. 1993; 42(2):119-29; discussion 129-30. DOI: 10.1016/0090-4295(93)90634-m. View

12.

De Coster R, Wouters W, Bruynseels J . P450-dependent enzymes as targets for prostate cancer therapy. J Steroid Biochem Mol Biol. 1996; 56(1-6 Spec No):133-43. DOI: 10.1016/0960-0760(95)00230-8. View

13.

JANKNEGT R, Abbou C, Bartoletti R, Bracken B, BRISSET J, Silva F . Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. J Urol. 1993; 149(1):77-82; discussion 83. DOI: 10.1016/s0022-5347(17)36003-2. View

14.

McLeod . Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer. Oncologist. 1997; 2(1):18-27. View

15.

Labrie F, Sugimoto Y, Luu-The V, Simard J, Lachance Y, Bachvarov D . Structure of human type II 5 alpha-reductase gene. Endocrinology. 1992; 131(3):1571-3. DOI: 10.1210/endo.131.3.1505484. View

16.

Thigpen A, Silver R, Guileyardo J, CASEY M, McConnell J, Russell D . Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest. 1993; 92(2):903-10. PMC: 294929. DOI: 10.1172/JCI116665. View

17.

Cabot A . II. The Question of Castration for Enlarged Prostate. Ann Surg. 1896; 24(3):265-309. PMC: 1425053. DOI: 10.1097/00000658-189607000-00036. View

18.

Crawford E, Nabors W . Total androgen ablation: American experience. Urol Clin North Am. 1991; 18(1):55-63. View

19.

Beland G . Combination of Anandron with orchiectomy in treatment of metastatic prostate cancer. Results of a double-blind study. Urology. 1991; 37(2 Suppl):25-9. DOI: 10.1016/0090-4295(91)80098-r. View

20.

Hieble J, Bylund D, Clarke D, Eikenburg D, Langer S, Lefkowitz R . International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev. 1995; 47(2):267-70. View